Amarantus Bioscience Valuation
| AMBS Stock | USD 0.0001 0.00 0.00% |
Amarantus Bioscience seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Amarantus Bioscience from analyzing the firm fundamentals such as current valuation of 6.59 M, and Price To Earning of (0.01) X as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Amarantus Bioscience's price fluctuation is out of control at this time. Calculation of the real value of Amarantus Bioscience is based on 3 months time horizon. Increasing Amarantus Bioscience's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Amarantus pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Amarantus Bioscience Holdings. Since Amarantus Bioscience is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Amarantus Pink Sheet. However, Amarantus Bioscience's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0E-4 | Real 8.4E-5 | Hype 9.6E-5 |
The intrinsic value of Amarantus Bioscience's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Amarantus Bioscience's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Amarantus Bioscience Holdings helps investors to forecast how Amarantus pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Amarantus Bioscience more accurately as focusing exclusively on Amarantus Bioscience's fundamentals will not take into account other important factors: Amarantus Bioscience Total Value Analysis
Amarantus Bioscience Holdings is presently forecasted to have valuation of 6.59 M with market capitalization of 3.13 M, debt of 20.72 M, and cash on hands of 178. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Amarantus Bioscience fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
6.59 M | 3.13 M | 20.72 M | 178 |
Amarantus Bioscience Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The newest return on assets of Amarantus implies not a very effective usage of assets in November.Amarantus Bioscience Profitability Analysis
Net Loss for the year was (10.58 M) with profit before overhead, payroll, taxes, and interest of 0.About Amarantus Bioscience Valuation
The pink sheet valuation mechanism determines Amarantus Bioscience's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Amarantus Bioscience based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Amarantus Bioscience. We calculate exposure to Amarantus Bioscience's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Amarantus Bioscience's related companies.Amarantus BioScience Holdings, Inc., a biopharmaceutical company, focuses on the development of diagnostic and therapeutic product candidates in the areas of neurology, psychiatry, ophthalmology, and regenerative medicine. Amarantus BioScience Holdings, Inc. was founded in 2008 and is headquartered in New York, New York. Amarantus Bioscience operates under Biotechnology classification in the United States and is traded on OTC Exchange.
8 Steps to conduct Amarantus Bioscience's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Amarantus Bioscience's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Amarantus Bioscience's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Amarantus Bioscience's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Amarantus Bioscience's revenue streams: Identify Amarantus Bioscience's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Amarantus Bioscience's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Amarantus Bioscience's growth potential: Evaluate Amarantus Bioscience's management, business model, and growth potential.
- Determine Amarantus Bioscience's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Amarantus Bioscience's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Amarantus Bioscience Growth Indicators
Investing in growth stocks can be very risky. If the company such as Amarantus Bioscience does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Retained Earnings | -115.6 M |
Additional Tools for Amarantus Pink Sheet Analysis
When running Amarantus Bioscience's price analysis, check to measure Amarantus Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amarantus Bioscience is operating at the current time. Most of Amarantus Bioscience's value examination focuses on studying past and present price action to predict the probability of Amarantus Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amarantus Bioscience's price. Additionally, you may evaluate how the addition of Amarantus Bioscience to your portfolios can decrease your overall portfolio volatility.